Cancer survivors: An expanding population with an increased cardiometabolic risk
- 1 September 2018
- journal article
- review article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 143, 432-442
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Hypertriglyceridemia is Frequent in Endometrial Cancer SurvivorsJapanese Journal of Clinical Oncology, 2013
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort StudyJNCI: Journal of the National Cancer Institute, 2012
- Body Composition Abnormalities in Long-Term Survivors of Pediatric Hematopoietic Stem Cell TransplantationThe Journal of Pediatrics, 2012
- Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular RiskCirculation, 2010
- Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor StudyJNCI: Journal of the National Cancer Institute, 2008
- High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantationBone Marrow Transplantation, 2008
- Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor StudyBlood, 2007
- Cardiovascular disease, hypertension, dyslipidaemia and obesity in patients with hypothalamic-pituitary diseasePostgraduate Medical Journal, 2007
- Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trialThe Lancet, 2007
- Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor studyBlood, 2006